Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Temporomandibular Joint Dysfunction Syndrome
Investigators at Innsbruck Medical University target temporomandibular joint dysfunction syndrome
May 21st, 2008
According to recent research from Innsbruck, Austria, "The objective of this study was to assess the effectiveness of low-level laser therapy ( LLLT) in the management of temporomandibular joint ( TMJ) pain in a random and double-blind research design. TMJ pain patients, randomly assigned, received 2 to 3 treatments per week for 8 weeks of active LLLT ( Helium Neon, 632.8 nm, 30 mW) ( n = 26) or sham LLLT ( n = 26)." "Measures of TMJ pain during function were evaluated at baseline and weeks 2, 4, and 8 after the first laser therapy. At the 8-week point, within-group improvements were present for TMJ pain during function, for both the active and sham LLLT groups ( P...
Source: Immunotherapy Weekly (2008-05-21)
|
